Background/Aims: Gastric cancer is a highly aggressive tumor containing cancer stem cells (CSCs), which participate in tumor initiation, therapeutic resistance, and tumor relapse. Prolinerich protein 11 (PRR11) has been shown to be up-regulated in human cancers; however, its role in gastric CSCs is unknown. We hypothesize that PRR11 may affect tumorigenicity of gastric CSCs. In this study, we explored the biological function and regulation of PRR11 in gastric CSCs. Methods: Expression of PRR11 was evaluated in gastric CSC cell line by real-time quantitative PCR and western blot. The effect of PRR11 on tumorigenicity was examined by interference with gene expression using lentiviral vector-loaded shRNA. A xenograft tumor model using NOD/SCID mice was established to examine the role of PRR11 in tumor development. Results: Data showed that PRR11 was highly expressed in gastric CSCs. PRR11 was responsible for the maintenance of self-renewal and tumorigenicity of gastric CSCs, and overexpression of exogenous PRR11 could restore the self-renewal of gastric non-CSCs. Furthermore, interference with PRR11 altered the expression of stemness transcription factors. Interestingly, MAPK signaling controlled PRR11 expression by increasing PRR11 protein stability, and maintained gastric CSCs self-renewal in a PRR11 dependent manner. Conclusions: PRR11 regulated selfrenewal and tumorigenicity of gastric CSCs through MAPK signaling, and could be used as a therapeutic target for gastric cancer.
Introduction
Gastric carcinoma (GC) is the fourth most common malignancy worldwide [1] . Although there have been important medical advances in the diagnosis and treatment of GC over the past few decades, the survival rate remains low [1] [2] [3] [4] . Novel treatment strategies are urgently needed.
Recently studies have demonstrated that a subpopulation of cancer cells, often referred to as cancer stem cells (CSCs) or tumor initiating cells (TICs) [5] , is capable of extensive proliferation, self-renewal, and increased frequency of tumor initiation [6] . Gastric CSCs can be enriched with several defined markers, including CD44, aldehyde dehydrogenase (ALDH), and Lgr5 [7, 8] . Stemness markers such as SOX2 and Oct-3/4 have also been accepted for the identification of gastric CSCs [9] . However, the key components and molecular mechanisms contributing to self-renewal and tumorigenicity of gastric CSCs are largely unknown.
The proline-rich protein 11 (PRR11) was identified as a novel gene and has an important role in both cell cycle progression and tumorigenesis [10] . PRR11 has been indicated as a potential novel target in the diagnosis and treatment of human lung cancer [11] . Through regulating important genes involved in cell cycles and tumorigenesis, PRR11 participates in the initiation and progression of lung cancer and epithelial-to-mesenchymal transition in breast cancer [11] . Our previous research showed that PRR11 widely activated in human gastric cancer, and was an independent prognostic factor for gastric cancer patients, which are consistent with the hypothesis that PRR11 functions as an oncogene in the development and progression of gastric cancer [12] . However, whether an increase in PRR11 expression is responsible for the expansion of gastric CSC populations is not known.
The objective of the study was to investigate the effect of PRR11 on gastric CSCs. We found that PRR11 participated in the self-renewal and tumorigenicity of gastric CSCs. We also found that MAPK signaling activity played an important role in maintaining PRR11 expression through increased PRR11 protein stability to maintain gastric CSCs self-renewal.
Materials and Methods

Cell Culture
Human gastric cancer cell lines (SGC-7901 and HGC-27) were purchased from Cell Bank, Chinese Academy of Sciences. All cells were grown in Dulbecco's modified Eagle's medium (Invitrogen) supplemented with 10% fetal bovine serum (Gibco) at 37°C in a humidified atmosphere containing 5% CO 2 .
Colony Formation
For analysis of colony formation, SGC-7901 and HGC-27 cells were thoroughly dissociated with 0.25% trypsin in 0.02% EDTA (Sigma, USA) to prepare single cell suspension. The cells were then plated in 6-well plates at a density of 200 cells/well in DMEM containing 10% FBS. After incubation for 2 weeks at 37°C, colonies containing more than 50 cells were counted after Giemsa staining.
Sphere Formation
For the sphere formation assay, 100 cells were seeded into Costar Ultra Low Cluster 24-well plates (Corning) and cultured in DMEM/F12 medium (Sigma) supplemented with 5ng/ml epidermal growth factor (EGF, sigma, USA), B27 supplement (1X, Invitrogen, USA), 20ng/mL basic fibroblast growth factor (Peprotech), and 10ng/mL hepatocyte growth factor (Peprotech). Cells were incubated at 37°C for 2 weeks and numbers of spheres were counted.
Lentiviral vector-loaded shRNA to interfere with PRR11 expression Lentiviral vector-loaded shRNA was used to interfere with PRR11 expression. Briefly, lentivirus expression plasmid containing small interference RNA targeting PRR11 was constructed by GENECHEM (Shanghai, China) and was used to infect the gastric CSCs in presence of 6 μg/ml polybrene. Cells were then selected by puromycin, and knockdown of PRR11 was confirmed by western blot. 
Western Blot
Total protein was prepared from lysates of SGC-7901 and HGC-27 gastric carcinoma cell lines. Western blots were performed in the standard manner using a goat polyclonal antibody against human PRR11 (dilution, 1:1000), SOX2 (dilution, 1:1000), OCT4 (dilution, 1:1000), c-Myc (dilution, 1:500), Nanog (dilution, 1:1000), GAPDH (dilution, 1:1000), and a horseradish peroxidase-conjugated anti-goat IgG antibody diluted 1:3000 as the secondary antibody. Proteins were detected by ECL detection reagent.
RNA extraction and real-time PCR
Real-time quantitative PCR reaction was performed using SYBR1 Premix Ex TaqTM kit (Takara, Kyoto, Japan) according to the manufacturer's instructions and conventional PCR assays were performed using previously described method [12] . GAPDH was used as an internal standard. The PCR cycle was performed according to previously published protocol [12] . Reactions and analysis were performed using the ABI PRISM 7300 PCR and detection system (Applied Biosystems, Carlsbad, CA). The primers used are as follow: PRR11: F: 5'-CGTATCTGCCACCGAGAACTT-3'; R: 5'-GAGATGGTCTTCAGTGCTTCCT-3'; GAPDH: F: , and 2 × 10 6 cells per mouse, respectively (n = 5). At the end of 6 weeks or longer until they reached an appropriate size, mice were euthanized, and xenografts were removed and measured. Tumor volume (TV) was calculated by the formula: TV = L (length) × W 2 (width) /2. The usage of the mice was approved by the experimental animal ethics committee of the hospital (No. 150126).
Statistical analysis
All experiments were conducted at least three times and the results were from representative experiments. Data were expressed as the mean ± SEM, and the statistical significance between testing and control groups was analyzed with SPSS10.0 statistical software. When two groups were compared, the unpaired Student's t test was used. χ2 test was used for analysis of in vivo xenografts. P < 0.05 was considered statistically significant.
Results
PRR11 was highly expressed in gastric CSCs
We previously reported that PRR11 was highly expressed in gastric tumor tissues, and played important roles in tumor progression [12] . However, its role in gastric CSCs is unknown. To understand the PRR11 regulated self-renewal and tumorigenicity of gastric CSCs, we firstly examined whether PRR11 expression was elevated in gastric CSCs using CD44 biomarker. Our results showed that the mRNA level (P<0.001, Fig. 1A ) and protein level (Fig. 1B ) of PRR11 were significantly elevated in gastric CSCs compared to those in 
PRR11 played roles in self-renewal and tumor-initiation of gastric CSCs
We next investigated the potential role of PRR11 in self-renewal and tumorigenicity of gastric CSCs. We first examined whether knockdown of PRR11 expression in gastric CSCs could inhibit their self-renewal and tumorigenicity. Three shRNAs targeting PRR11 were designed and shPRR11#1 exhibited the strongest reduction of PRR11 protein levels in gastric cancer cell line SGC-7901 ( Fig. 2A) , which was used in subsequent experiments. Knockdown of PRR11 expression in gastric CSCs significantly reduced the efficiency of sphere formation (42.1±3.8 vs. 9.7±1.2, P<0.001, Fig. 2B ) and clone formation (72.3±2.5 vs. 29.8±1.3, P<0.001, Fig. 2C ). We next established a xenograft tumor model using NOD/SCID mice to examine the role of PRR11 in tumor development. Compared with control gastric CSCs, PRR11-KD gastric CSCs required more cells and longer incubation time to generate tumor with equivalent size in vivo (Fig. 2D-2F ). To quantify the tumor initiating capacity of PRR11-KD gastric CSCs, we transplanted cells at different cell numbers (10 3 , 5×10 3 and 10 4 ) per recipient. The incidence of tumors in mice receiving gastric CSCs was significantly higher than that in the PRR11-KD gastric CSC cohorts (Fig. 2G) . Limiting dilution analysis showed that the frequency was significantly higher in gastric CSCs compared with PRR11-KD counterparts (P=0.0271, Fig.  2H ). These findings suggest that a high level of PRR11 expression in gastric CSCs plays an essential role in self-renewal and tumorigenicity.
Overexpression PRR11 rendered gastric non-CSCs to behave like CSCs
We next infected gastric cancer cell line SGC-7901 with lentiviral vector containing PRR11, and established PRR11 stably overexpressing cell line (Fig. 3A) . PRR11 overexpression increased clone and sphere formation efficiencies significantly (P<0.05, Fig. 3B and 3C ). Tumor initiation assay showed that four out of five animals developed small tumors when gastric non-CSCs were implanted, whereas all animals developed large tumors when gastric non-CSCs expressing PRR11 were implanted (Fig. 3D) . Tumor volume and tumor weight were significantly increased in animals implanted with gastric non-CSCs expressing PRR11 compared with liver non-CSCs (P<0.05, Fig. 3E and 3F) . These data further demonstrate that PRR11 plays a fundamental role in maintaining self-renewal of gastric CSCs. 
PRR11 regulated stemness properties in gastric CSCs
It has been reported that pluripotent transcription factors (SOX2, Oct4, Nanog, and c-Myc,) are involved in self-renewal of CSCs [13, 14] . To explore the molecular mechanisms involved in PRR11 mediated self-renewal and tumorigenic potential of gastric CSCs, we first examined the expression of these genes in gastric CSCs upon PRR11 silencing. Our results showed that PRR11 knockdown in gastric CSCs decreased SOX2, Oct4, Nanog, and c-Myc expression levels (Fig. 4A) . We also found that overexpressed PRR11 in gastric non-CSCs increased SOX2, Oct4, Nanog, and c-Myc expression levels (Fig. 4B) . Together, these data suggest that PRR11 may regulate stemness transcriptional factors expression for priming self-renewal of gastric CSCs.
MAPK signaling regulated the PRR11 protein stability of gastric CSCs
It has been reported that MAPK signaling plays an important role in CSCs self-renewal and tumorigenicity [15] [16] [17] . However, how MAPK signaling sustains gastric CSCs self-renewal and tumorigenicity remains largely unknown. To investigate whether MAPK signaling affects PRR11 expression to enhance self-renewal of gastric CSCs, we treated gastric CSCs with the MAPK signaling inhibitor and measured PRR11 expression. Our results showed that PRR11 protein was significantly lower in gastric CSCs treated with MAPK signaling inhibitor Dorsomorphin (Fig. 5A ), but not PRR11 mRNA levels (P>0.05, Fig. 5B ).
We hypothesized that MAPK signaling may regulate the stability of the PRR11 protein. To do this, we measured PRR11 half-life in gastric CSCs treated with cyclohexamide (HCX), an inhibitor of protein translation. The half-life of PRR11 was short in gastric CSCs after treatment with MAPK signaling inhibitor Dorsomorphin (Fig. 5C) . We treated gastric CSCs with the proteasome inhibitor MG132 with or without Dorsomorphin. Our results showed that treatment with MG132 could restore the reduced PRR11 protein level by Dorsomorphin (Fig. 5D) . These results indicate that MAPK signaling may inhibit proteasome activity to maintain PRR11 protein stability. Cellular Physiology and Biochemistry
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MAPK signaling maintained gastric CSCs self-renewal on a PRR11 dependent manner
Above results showed that PRR11 plays an important role in self-renewal and tumorigenicity of gastric CSCs, and MAPK regulates PRR11 protein stability. We expected that MAPK signaling though PRR11 may improve the self-renewal in gastric CSCs. To test this idea, we first overexpressed PRR11 in gastric CSCs in which MAPK signaling was inhibited by Dorsomorphin. Overexpression of exogenous PRR11 could restore the decreased clone and sphere formation efficiencies induced by inhibition of MAPK signaling in gastric CSCs (Fig.  6A and 6B ). These data demonstrate that MAPK signaling regulates gastric CSCs self-renewal on a PRR11 dependent manner.
Discussion
The CSCs possess critical roles in gastric cancer initiation, progression, and recurrence associated with resistance to radio-and chemotherapy [18] . In the present study, we showed that PRR11 was highly expressed in a subpopulation of gastric cancer cells with stem-like characteristics, and sat at the center of a signaling network, since changes in its expression pattern could drastically alter the biology properties of gastric CSCs and non-CSCs. The higher level of PRR11 expression in gastric CSCs appeared to be required to maintain the biological features of those cells, including self-renewal, stemness, and tumor initiation in vivo. Therefore, the pluripotent-like signature displayed by gastric CSCs could be at least partially attributed to the upregulation of PRR11. Moreover, we provided evidence that PRR11 possesses the capability to reprogram gastric non-CSCs with differentiated features to resemble CSCs-like status.
Because of CSCs are believed to up-regulation of multiple stemness genes to exert their regulatory effects on specific biological processes [19] . In this case, it was not surprising that we identified that knocked down or over-expression PRR11 affected stemness expression. However, the detailed mechanisms of PRR11 regulating pluripotency factors in gastric CSC need further exploration. 
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A particularly interesting aspect of MAPK signaling in cancer progression is that the role of MAPK signaling may be linked to PRR11, which has emerged as a potential therapeutic target for cancers. In this study, our results suggested that MAPK signaling regulated the ability of PRR11 protein though the inhibition of ubiquitin-proteasome activity. This notion is clearly demonstrated by that the antagonist for MAPK signaling could block the self-renewal property of gastric CSCs. However, the stability of PRR11 itself is poorly understood, and further studies are required to determine whether MAPK signaling-related proteins bind directly to PRR11 itself or another protein involved in PRR11 degradation.
In addition, a rapidly growing body of evidence has shown PRR11 as potential targets for cancer therapy [11, 20] . It has been reported that MAPK signaling was involved in a variety of cancers, such as lung cancer, pancreatic cancer, prostate cancer, melanoma and colon cancer [21, 22] . MAPK signaling plays an important role in cancer formation, progression, therapy resistance and causing poor patient prognosis. Taken together, the striking inhibitory effect of PRR11 antagonists on tumor growth strongly suggests that further efforts toward development of anti-PRR11-based therapeutics are fully warranted.
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